2025-12-28 - Analysis Report
Okay, here's a comprehensive report on Lam Research (LRCX) based on the data you provided:

**1) Performance vs. S&P 500 (VOO)**

*   **LRCX Overview:** Lam Research Corp. supplies wafer fabrication equipment and services to the semiconductor industry.
*   **LRCX Cumulative Return:** 270.69%
*   **VOO Cumulative Return:** 103.21%
*   **Divergence:** 157.7
*   **Relative Divergence:** 100.0

**Analysis:** LRCX has significantly outperformed the S&P 500 (VOO) over the period examined. The divergence of 157.7 indicates a substantial difference in cumulative returns, and the relative divergence of 100 suggests LRCX is currently at the top of its historical divergence range compared to VOO. This strong outperformance suggests LRCX has been a more lucrative investment during this period.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD   | Alpha  | Beta | Cap(B) |
|------------|---------|-------|--------|------|--------|
| 2015-2017  | 84.0%   | 67.8% | 56.0%  | 0.0  | 23.2   |
| 2016-2018  | 18.0%   | 68.1% | 3.0%   | 0.1  | 17.2   |
| 2017-2019  | 53.0%   | 82.9% | 31.0%  | 1.2  | 36.9   |
| 2018-2020  | 66.0%   | 82.9% | 42.0%  | 1.1  | 59.5   |
| 2019-2021  | 119.0%  | 82.9% | 73.0%  | 1.0  | 90.7   |
| 2020-2022  | -10.0%  | 79.2% | -9.0%  | 0.9  | 53.0   |
| 2021-2023  | -13.0%  | 80.4% | -15.0% | 1.0  | 98.8   |
| 2022-2024  | -52.0%  | 80.4% | -72.0% | 1.0  | 91.1   |
| 2023-2025  | 182.0%  | 80.4% | 114.0% | 0.9  | 224.6  |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate fluctuates significantly, showcasing periods of high growth (e.g., 2019-2021, 2023-2025) and declines (2020-2022, 2022-2024).
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk and volatility in LRCX's price. MDD are very high in all periods presented.
*   **Alpha:** Alpha, representing performance above the benchmark, is positive during growth periods and negative during declines, confirming LRCX's sensitivity to market conditions.  Notably high Alpha during 2023-2025.
*   **Beta:** Beta values are around 1, suggesting LRCX's price generally moves in line with the market, although periods of 1.1 and 1.2 Beta are observed, representing higher volatility compared to the overall market.
*   **Cap:** The Market Capitalization consistently grows from 2015 to 2025, except for 2020-2022 and 2022-2024 period.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 178.07
*   **Previous Close:** 177.33
*   **Change:** 0.42
*   **5-day SMA:** 175.62
*   **20-day SMA:** 164.92
*   **60-day SMA:** 154.97

**Analysis:**  The stock is trading above all its short-term and medium-term moving averages (5-day, 20-day, and 60-day SMAs). The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA. This is a bullish indicator, suggesting upward momentum.  The small change from the previous close indicates relatively stable recent trading.

**3) Technical Indicators & Expected Return**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended)
*   **RSI:** 67.74
*   **PPO:** 0.76
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-04)
*   **Recent Relative Divergence Change:** 9.1 (+) 단기상승 (Short-term Increase)
*   **Expected Return:** 14.2%

**Analysis:**

*   **MRI:** A high MRI score of 1.0 signals a generally favorable market environment for investment, according to this indicator.
*   **RSI:** An RSI of 67.74 indicates the stock is approaching overbought territory (typically above 70). This suggests the recent upward momentum may be unsustainable in the short term.
*   **PPO:** A positive PPO of 0.76 suggests the stock's short-term moving average is above its long-term moving average, further reinforcing the bullish trend.
*   **Hybrid Signal:** The hybrid signal suggests a strong buy recommendation, allocating 90% of cash.
*   **Recent Relative Divergence Change:** Indicates a recent short-term increase, supporting the bullish trend.
*   **Expected Return:** A 14.2% expected return over a long-term (2+ years) horizon is attractive and suggests confidence in LRCX's future performance relative to the broader market.

**4) Recent News & Significant Events**

*   **CEO Share Sale & Analyst Targets:** News about CEO share sales can sometimes create uncertainty, but analyst target revisions suggest ongoing monitoring and adjustments based on company performance and market outlook.
*   **Citi Raises PT on LRCX Stock:** A raised price target from Citi is a positive signal, reflecting their bullish outlook on the company.
*   **Lam Research (NASDAQ:LRCX) Stock Price Up 1.2%:** The headline confirms positive movement in the stock price.
*   **Lam Research, IBD stock of the day, hits all-time high on 2026 prospects:** Hitting an all-time high driven by future prospects is very positive.
*   **Lam Research Stock (LRCX) Climbs to Record Close as AI-Driven Chip Equipment Cycle Stays in Focus:** Highlights the positive impact of AI on the company's sector.
*   **Why Lam Research (LRCX) Stock Is Up Today:** Provides potential reasons for the current stock appreciation.

**Analysis:**  The news flow is predominantly positive. Analysts are generally optimistic (Citi's price target increase). The recurrent theme of AI driving the chip equipment cycle is a significant tailwind for Lam Research.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean 1.79)
*   **Target Price:** Average: 166.97, High: 210.00, Low: 84.00
*   **Recent Rating Changes:** No specific rating changes provided, but the consensus indicates an overall positive view.

**Analysis:** The analyst consensus is "Buy," indicating a generally positive outlook on the stock. However, the average target price (166.97) is slightly below the current price (178.07), suggesting the stock might be slightly overvalued based on average analyst expectations. The high target price (210.00) suggests some analysts are significantly more bullish.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-10-24 | 1.24 | 5.32 B$    |
| 2025-04-25 | 1.04 | 4.72 B$    |
| 2025-01-31 | 0.93 | 4.38 B$    |
| 2024-10-28 | 0.86 | 4.17 B$    |
| 2025-10-24 | 0.86 | 4.17 B$    |

**Analysis:**  Both EPS and revenue have generally been increasing over the recent quarters. This trend indicates positive business momentum and improving profitability.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $5.32B  | 50.43%        |
| 2025-06-30 | $5.17B  | 50.08%        |
| 2025-03-31 | $4.72B  | 49.02%        |
| 2024-12-31 | $4.38B  | 47.37%        |
| 2024-09-30 | $4.17B  | 48.05%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-09-30 | $10.19B   | 15.39%   |
| 2025-06-30 | $9.86B    | 17.44%   |
| 2025-03-31 | $9.51B    | 13.99%   |
| 2024-12-31 | $8.81B    | 13.52%   |
| 2024-09-30 | $8.47B    | 13.18%   |

**Analysis:**

*   **Revenue & Profit Margin:** Both revenue and profit margin are showing a positive trend, indicating strong operational performance.
*   **Equity & ROE:** Equity is steadily increasing, suggesting the company is growing its asset base. ROE (Return on Equity) is relatively high and fluctuating, indicating efficient use of shareholder's equity to generate profits.

**7) Comprehensive Analysis (Summary)**

Lam Research (LRCX) is demonstrating strong performance and positive momentum. The stock has significantly outperformed the S&P 500.  Recent news is positive, highlighting the impact of AI and analyst optimism. Financials show increasing revenue, profit margins, equity, and ROE. Technical indicators suggest the stock is approaching overbought territory but is currently in a bullish trend. Analyst consensus is a "Buy," but the average target price is slightly below the current price, which might warrant caution. The high expected return of 14.2% suggests a favorable long-term outlook, provided one is aware of the high MDD.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.